Drug Side Effects
Search
OVARIAN CLEAR CELL CARCINOMA
OVARIAN CLEAR CELL CARCINOMA
was reported 39 times
These drug classes are most commonly taken by patients reporting OVARIAN CLEAR CELL CARCINOMA:
#
Drug
Count
0
Vascular Endothelial Growth Factor Inhibitor [EPC]
14
1
Microtubule Inhibitor [EPC]
9
2
Platinum-based Drug [EPC]
9
3
Programmed Death Receptor-1 Blocking Antibody [EPC]
6
4
Alkylating Drug [EPC]
3
5
Estrogen [EPC]
3
6
Interferon beta [EPC]
3
7
Kinase Inhibitor [EPC]
3
8
Topoisomerase Inhibitor [EPC]
3
9
Progestin [EPC]
2
10
Tumor Necrosis Factor Blocker [EPC]
2
11
Angiotensin 2 Receptor Blocker [EPC]
1
12
Echinocandin Antifungal [EPC]
1
13
Factor Xa Inhibitor [EPC]
1
14
Folate Analog Metabolic Inhibitor [EPC]
1
15
GLP-1 Receptor Agonist [EPC]
1
16
Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]
1
17
Integrin Receptor Antagonist [EPC]
1
18
P2Y12 Platelet Inhibitor [EPC]
1
19
Parathyroid Hormone-Related Peptide Analog [EPC]
1
20
Poly(ADP-Ribose) Polymerase Inhibitor [EPC]
1
21
Provitamin D2 Compound [EPC]
1
22
Sphingosine 1-phosphate Receptor Modulator [EPC]
1
23
mTOR Inhibitor Immunosuppressant [EPC]
1